Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
McKinsey
Mallinckrodt
Boehringer Ingelheim
Express Scripts

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Formulation information for generic ingredient: gadoterate meglumine

See Plans and Pricing

« Back to Dashboard

Gadoterate meglumine

CASRN: 92943-93-6

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Mallinckrodt
Harvard Business School
Merck
Colorcon